Koninklijke Philips N.V. (PHG)

Healthcare · NYQ · US

$23.80-2.58% today

Price as at 1 Oct 2026, 15:13 UTC. Quotes are delayed.

Fundamentals

Market cap$24.21B
P/E ratio19.1
Dividend yield4.09%
Revenue growth (YoY)+0.5%
Profit margin6.3%
Return on equity10.2%
52-week range$23.77 to $33.44

Valuation and ratings

Fair value estimate$50.05
Upside to fair value+110.3%
Analyst target (mean)$32.21
Analyst range$26.75 to $41.00
Analysts with price targets5
Consensus viewhold
Moat score48/100
Overall rating76/100, high quality

Fair value: $50.05 (+110.3%), see how we got there

Koninklijke Philips N.V. trades at $23.80, which is 110% below the $50.05 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.

Our moat model scores it 48 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

It changes hands at 19.1 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.

PHG dividend history

Dividend yield4.09%
Paid, trailing 12 months$1.01 per share
Most recent payment$1.01, ex 13 May 2026
Consecutive years paid1

Dividends per share by year

YearTotal per sharePayments
2026 (year to date)$1.011
2025$0.9671
2022$0.9641
2021$1.031
2019$0.9601
2018$0.9921
2017$0.8631
2016$0.8831
2015$0.9091
2014$1.101
2013$0.9821

Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.

PHG earnings and analyst estimates

Next earnings date3 Nov 2026 (in 32 days)
EPS estimate, next year$1.90
Expected EPS growth+8.0%
Expected revenue growth+4.4%

Recommendation mix, 5 published ratings

2 buy3 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Koninklijke Philips N.V.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Industry: Medical DevicesEmployees: 63,670HQ: Netherlands

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

PHG passes 5 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Super investor ownership

7 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in PHG

We hold 11 disclosed trades in PHG by members of Congress and executive-branch officials. The latest 5:

  • Alan Armstrong · SenateBuy · $1,001 - $15,000 · traded 30 Mar 2026 · disclosed 21 Jul 2026
  • Earl Blumenauer · HouseBuy · $1,001 - $15,000 · traded 12 Feb 2024 · disclosed 2 Mar 2024
  • Daniel Goldman · HouseSell · $15,001 - $50,000 · traded 10 Jul 2023 · disclosed 13 Aug 2023
  • Earl Blumenauer · HouseBuy · $1,001 - $15,000 · traded 27 Jul 2022 · disclosed 8 Aug 2022
  • Dean Phillips · HouseBuy · $1,001 - $15,000 · traded 8 Jun 2020 · disclosed 7 Jul 2020

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

PHG peers

The largest companies in the same industry (Medical Devices), then in the same sector.

Every healthcare company we cover is on the Healthcare hub.

Common questions

Is Koninklijke Philips N.V. (PHG) undervalued?

Against our fair value estimate of $50.05, PHG at $23.80 is 110% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.

Which funds own PHG?

7 of the institutions we track reported a position in PHG in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.

What is PHG's P/E ratio?

PHG trades at 19.1 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.

Does Koninklijke Philips N.V. (PHG) pay a dividend?

Yes. Koninklijke Philips N.V. yields 4.09% at the current share price. It has paid $1.01 per share over the trailing twelve months. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.

When does PHG report earnings next?

Koninklijke Philips N.V. is scheduled to report on 3 Nov 2026. Companies move earnings dates, so read it as scheduled rather than certain.

Where does SteadyShares get its PHG data?

Fundamentals for PHG come from company filings and exchange data, as listed on NYQ; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 15:13 UTC and is delayed. Our data quality score for this company is 100/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for PHG, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.